Sept. 26, 2019— When one discusses the 340B drug pricing program, the talk often turns to complex compliance and implementation issues such as actual acquisition prices, split billing software, and penny pricing. But it’s important to remember that there also are dedicated people working with all this complexity to make the program a success in helping patients. We recently … [Read more...]